NF1 with Plexiform Neurofibromas Study: information for patients and carers
28 January 2021
Do you have Neurofibromatosis Type 1 (NF-1) with plexiform neurofibromas (PN) or do you care for a child with NF-1 and PN? If so, we would like to speak to you for our research study, which aims to better understand how patients and carers experience living with NF-1 and PN and how this impacts their daily lives.
What would we ask you to do?
The research team will first ask you a few short questions to confirm you are eligible for the study over email. If you are eligible, you will be invited to take part in a telephone interview lasting around one hour. Participants will speak with a researcher from Acaster Lloyd Consulting Ltd., an independent research consultancy.
You will receive £30 via a bank transfer for taking part in the study.
What would we do with your data?
Interviews will be audio-recorded and transcribed verbatim. All transcripts will be anonymised so that the identity of study participants will not be revealed in any reports. Data from all study participants will be combined and analysed together. The objective of the study is to understand how NF-1 with PN impacts patients’ and carers’ lives.
The anonymised study results will be used to help inform those who make decisions about whether treatments will be made available to the NHS (i.e. NICE in the UK). We anticipate that the study results will be presented at academic conferences and published in peer-reviewed medical journals.
Are you interested in taking part in the study?
If you are interested in taking part or have questions about the research, you can contact us by emailing: claire.lawrence@acasterlloyd.com
Filter News
Christmas Message from the NTUK Head Office Team
Happy Christmas from all of us at Nerve Tumours UK
Read More
CAR: Social media experiences of young people with visible differences
Young people with visible differences discuss the positive and negative aspects of using social media - find out more
Read More
Chair, Richard Goode and family brave the West Wittering 10k
Richard Goode, Chair of the NTUK Board of Trustees, and his family took on the Wittering Beach 10k
Read More
National NF2 Meeting 2025
On Tuesday 4th November, the NF2 clinical community and national charities gathered in Manchester for the biannual meeting.
Read More
Juliette Buttimore joins our Medical Advisory Board
Juliette Buttimore, Nurse Consultant, specialising in NF2-related schwannomatosis and skull base conditions
Read More
Freddie’s motto: “Be kind, be brave and be happy”
Meet Freddie: diagnosed with NF1 as a baby, he loves performing and has a role in the film Christmas Karma
Read More
Understanding Neurofibromatosis Type 1 (NF1): A surgeon’s thoughts
Christopher Duff is a plastic surgeon working with NF1 patients in Manchester, he answers some common questions from patients
Read More
Understanding NF1: A guide to skin neurofibromas and their treatment
This guide is for people with NF1 and explains what neurofibromas are and what treatments might help.
Read More